past
two
decad
cellpenetr
peptid
cpp
becom
increasingli
popular
research
applic
numer
studi
physiochem
characterist
behavior
cpp
variou
environ
likewis
mechan
entri
deliveri
capabl
peptid
also
extens
research
besid
fundament
issu
enorm
interest
deliveri
capabl
peptid
famili
cpp
promis
mostli
nontox
deliveri
vector
candid
numer
medic
applic
gene
silenc
transgen
deliveri
splice
correct
late
howev
emerg
fi
eld
studi
besid
highprofi
le
gene
therapi
applicationsth
use
peptid
cpp
combat
variou
infect
caus
harm
bacteria
fungi
virus
chapter
aim
provid
short
overview
histori
properti
cpp
follow
thorough
descript
antimicrobi
antivir
peptid
achiev
analyz
origin
peptid
give
overview
mechan
action
discuss
variou
practic
applic
ongo
suggest
base
research
cpp
class
divers
peptid
typic
amino
acid
length
unlik
peptid
cross
cellular
plasma
membran
cpp
famili
peptid
structur
divers
share
abil
transloc
wide
rang
differ
bioactiv
molecul
live
cell
list
avail
cpp
grown
rapidli
cpp
employ
varieti
applic
cpp
serv
vector
success
facilit
intracellular
transport
cargo
smallmolecul
therapeut
agent
protein
quantum
dot
mri
contrast
agent
vitro
vivo
addit
effi
cient
transport
system
lower
cytotox
varieti
cell
line
compar
deliveri
method
mechan
intern
cpp
cargo
well
understood
recent
subject
controversi
cpp
interact
multipl
cell
surfac
molecul
includ
membran
lipid
membraneassoci
proteoglycan
cpp
taken
cell
via
multipl
pathway
direct
transloc
membran
bilay
endocytosismedi
uptak
although
molecul
enter
cell
prefer
direct
membran
transloc
pathway
endocytosi
compos
two
step
endocytot
entri
endosom
escap
major
cellular
uptak
pathway
cpp
report
point
endocytosi
occur
variou
format
classifi
ed
caveola
andor
lipid
raftmedi
endocytosi
micropinocytosi
clathrinmedi
endocytosi
via
cholesteroldepend
clathrinmedi
endocytosi
endocytosi
pathway
propos
base
fact
cpp
uptak
cell
found
adopt
energydepend
mechan
howev
cellular
uptak
complet
prohibit
low
temperatur
presenc
endocytosi
inhibitor
suggest
nonenergi
consum
rout
recent
fi
nding
strong
peptidelipid
interact
support
direct
transloc
peptid
across
membran
addit
mani
studi
also
propos
cellular
uptak
follow
multipl
rout
depend
experiment
condit
specifi
c
cpp
sequenc
cargo
structur
besid
cpp
anoth
import
categori
cation
membran
peptid
antimicrobi
peptid
amp
antimicrobi
peptid
major
class
antibacteri
agent
share
amphiphil
cation
structur
properti
cellpenetr
peptid
amp
known
cation
howev
concept
amp
need
cation
chang
later
discoveri
neg
charg
amp
exampl
discov
frog
skin
dermicidin
secret
human
sweat
gland
tissu
anion
peptid
also
posit
net
charg
normal
rang
due
frequent
presenc
lysin
arginin
amino
acid
sequenc
addit
nearli
structur
often
consist
hydrophob
residu
kill
broad
spectrum
microb
includ
bacteria
fungi
destroy
cell
membran
import
compon
innat
immun
system
mani
anim
plant
cpp
amp
share
common
characterist
cpp
amp
similar
structur
motif
amino
acid
composit
differ
biolog
activ
within
lipid
membran
common
group
interact
cell
membran
compon
charg
amino
acid
residu
peptid
probabl
fi
rst
step
cell
associ
lead
cellular
uptak
anion
phospholipid
phosphat
group
lipopolysaccharid
gramneg
bacteria
acid
polysaccharid
teichoic
acid
lipoteicho
acid
gramposit
bacteria
membran
compon
cell
surfac
respons
gener
overal
neg
net
charg
make
bind
posit
charg
amphipath
peptid
possibl
furthermor
lipid
bilay
bacteri
membran
contain
mainli
lipid
neg
charg
phospholipid
headgroup
fungi
contrast
exhibit
zwitterion
lipid
bilay
composit
upon
uptak
driven
hydrophob
cterminu
particular
amino
acid
peptid
sequenc
result
accumul
peptid
fi
nalli
induc
strong
hydrophob
interact
membran
charg
interact
cation
residu
lipid
essenti
biolog
function
mani
membran
peptid
protein
exampl
cellular
transloc
cpp
membran
disrupt
amp
ratio
cation
lysin
ly
arginin
arg
residu
infl
uenc
membran
select
sinc
guanidino
function
arginin
promot
effi
cient
interact
eukaryot
membran
compar
lysin
howev
often
expens
increas
cytotox
high
ly
content
correl
select
toward
bacteri
cell
eukaryot
cell
furthermor
abil
cpp
permeat
cell
membran
appear
directli
link
propens
fold
welldefi
ned
secondari
structur
interact
biolog
membran
likewis
antimicrobi
activ
amp
depend
propens
form
highli
basic
arg
guanidinium
ly
ammonium
group
remain
proton
physiolog
ph
condit
thu
function
hydrogen
bond
hbond
donor
variou
proteinprotein
proteinlipid
interact
lipid
membran
guanidinium
group
protein
side
chain
form
branch
moieti
interact
water
lipid
molecul
past
year
mani
cpp
amp
extens
investig
elucid
structur
basi
cation
macromolecul
interact
membran
lipid
water
two
exampl
amp
recent
studi
includ
human
neutrophil
repres
mani
amp
disulfi
delink
structur
argrich
sequenc
belong
famili
antimicrobi
peptid
mediat
host
innat
immun
respons
amp
adopt
rigid
amphipath
secondari
structur
either
two
cpp
tat
penetratin
fi
rst
two
discov
also
frequent
appli
cpp
display
turnrich
conform
random
coil
structur
lipid
bilay
respect
suggest
absenc
intraor
intermolecular
hbond
conform
high
molecular
mobil
may
hallmark
cpp
differenti
amp
due
similar
argrich
structur
motif
cpp
amp
strong
arglipid
argwat
interact
stabil
hydrophob
peptid
membran
neutral
water
solvat
thu
facilit
insert
howev
cpp
interact
cellular
membran
noninvas
manner
amp
function
disrupt
lipid
membran
addit
cpp
also
experi
chargecharg
interact
distal
phosphat
layer
guanidiniumphosph
interact
stabil
cpp
peptid
lipid
facilit
insert
plastic
conform
high
mobil
promot
transloc
amp
preferenti
attack
intern
cellular
target
similar
transloc
mechan
report
buforin
transloc
effi
cientli
littl
membran
activ
structur
orient
bilay
observ
similar
magainin
result
model
propos
wherebi
buforin
molecul
would
form
toroid
pore
magainin
less
stabl
would
result
shorter
pore
lifetimeswith
concomit
decreas
permeabilizationat
time
transloc
rate
would
increas
pore
disintegr
actual
transloc
step
would
becom
frequent
model
support
result
show
presenc
bilay
compon
prevent
format
toroid
pore
dioleyl
phosphatidylethanolamin
inhibit
buforin
transloc
wherea
anion
phospholipid
decreas
charg
repuls
cation
peptid
molecul
stabil
pore
point
signifi
cant
leakag
fl
ipfl
op
observ
buforin
transloc
also
shown
withstand
cargo
addit
demonstr
attach
green
fl
uoresc
protein
make
peptid
promis
candid
develop
cpp
membranethin
effect
propos
amp
magainin
peptid
aggreg
surfac
membran
decreas
local
surfac
tension
allow
peptid
intercal
membran
antimicrobi
peptid
geneencod
ribosom
synthes
polypeptid
usual
common
characterist
small
peptid
vari
number
fi
hundr
amino
acid
strongli
cation
pi
heatstabl
min
drug
fast
effect
eukaryot
cell
total
amp
discov
predict
synthes
date
natur
amp
isol
character
produc
practic
live
organ
rang
prokaryot
eg
bacteria
eukaryot
eg
protozoan
fungi
plant
insect
anim
anim
amp
mostli
found
tissu
organ
expos
airborn
pathogen
believ
fi
rst
line
innat
immun
defens
virus
bacteria
fungi
sever
type
eukaryot
cell
involv
amp
product
lymph
epitheli
cell
gastrointestin
genitourinari
system
phagocyt
lymphocyt
immun
system
addit
direct
involv
innat
immun
amp
also
found
infl
uenc
infl
ammatori
respons
infect
short
amp
abil
kill
pathogen
microorgan
includ
gramposit
gramneg
bacteria
virus
protozoa
fungi
contrast
convent
antibiot
amp
appear
bactericid
kill
bacteria
instead
bacteriostat
inhibit
growth
destroy
bacteria
within
minut
rate
faster
bacteria
growth
rate
amp
commonli
classifi
ed
four
group
accord
origin
origin
insect
anim
synthesi
genet
engin
microorgan
possibl
make
fulli
synthet
peptid
chemic
synthesi
antimicrobi
peptid
discoveri
amp
date
back
dubo
extract
antimicrobi
agent
soil
bacillu
strain
extract
demonstr
protect
mice
pneumococci
infect
follow
year
hotchkiss
dubo
fraction
extract
identifi
ed
amp
name
gramicidin
anoth
amp
tyrocidin
discov
found
effect
gramneg
gramposit
bacteria
howev
tyrocidin
exhibit
toxic
human
blood
cell
year
anoth
amp
isol
plant
antimicrobi
antivir
applic
cellpenetr
peptid
triticumaestivum
later
name
purothionin
found
effect
fungi
pathogen
bacteria
fi
rst
report
animalorigin
amp
defensin
isol
rabbit
leukocyt
follow
year
bombinin
epithelia
lactoferrin
cow
milk
describ
time
also
proven
human
leukocyt
contain
amp
lysosom
common
molecular
entri
rout
ampsit
depend
natur
peptid
membran
lipid
composit
peptidelipid
ratio
mechan
compris
sever
stage
yet
fulli
understood
despit
extens
studi
necessari
step
peptid
associ
membran
lipid
result
longrang
defect
differ
molecular
mechan
postul
barrelstav
toroidalwormhol
pore
format
aggreg
channel
format
surfactantlik
interact
assum
aggregationoligomer
amp
cytoplasm
membran
necessari
step
lead
membran
lysi
amp
report
date
classifi
ed
base
one
follow
four
type
base
secondari
structur
featur
cathelicidin
linear
structur
defensin
structur
bactenecin
loop
structur
extend
helic
predomin
one
amino
acid
among
structur
group
structur
common
peptid
studi
amp
date
best
known
exampl
amp
protegrin
magainin
cyclic
indolicin
coil
indolicin
peptid
without
presenc
cystein
sequenc
melittin
peptid
compos
least
two
disulfi
de
bond
strand
protegrin
amp
intermolecular
disulfi
de
bond
exhibit
loophairpinlik
structur
bactenecin
belong
third
group
fi
nal
group
peptid
predomin
one
distinct
amino
acid
prolineargininerich
peptid
design
novel
amp
requir
consider
sever
factor
includ
secondari
structur
amphipath
presenc
posit
charg
residu
believ
amphipath
secondari
structur
requir
order
amp
function
although
exact
mechan
action
still
unclear
point
tossi
et
al
design
amp
gener
base
amino
acid
residu
analogu
natur
peptid
eg
congen
differ
one
residu
posit
shorten
contain
delet
well
hybrid
amp
compos
fragment
two
differ
natur
peptid
b
amino
acid
residu
maxim
amphipath
natur
amp
c
amino
acid
sequenc
combinatori
librari
amino
acid
sequenc
pattern
known
natur
occur
peptid
domain
import
factor
consid
design
amp
length
peptid
net
charg
amphipath
possibl
modifi
cation
phosphoryl
addit
amino
acid
methyl
amid
glycosyl
format
disulfi
de
linkag
proteolyt
cleavag
gener
accept
posit
charg
peptid
interact
directli
neg
charg
cellular
membran
bacteri
cell
result
increas
membran
permeabl
lead
rapid
cell
death
group
amp
divid
antibacteri
b
antivir
c
antifung
antiparasit
e
anticanc
peptid
amp
kill
bacteria
inhibit
import
pathway
insid
cell
dna
replic
protein
synthesi
antivir
amp
neutral
virus
integr
either
viral
envelop
host
cell
membran
amp
integr
viral
envelop
caus
membran
instabl
render
virus
unabl
infect
host
cell
amp
also
reduc
bind
virus
host
cell
antifung
peptid
capabl
bind
chitin
bind
abil
help
amp
target
fungal
cell
effi
cientli
cell
walltarget
antifung
amp
kill
target
cell
disrupt
integr
fungal
membran
increas
permeabil
plasma
membran
form
pore
directli
exampl
antiparasit
peptid
cathelicidin
abl
kill
caernohabd
elegan
form
pore
cell
membran
even
though
parasit
microorgan
multicellular
mode
action
antiparasit
peptid
amp
kill
cell
directli
interact
cell
membran
anticanc
peptid
also
known
host
defens
peptid
unction
target
cell
membran
date
host
defens
peptid
known
antimicrobi
peptid
repres
novel
class
therapeut
agent
may
use
treatment
rang
infecti
diseas
howev
order
develop
antimicrobi
peptid
therapeut
use
number
technolog
hurdl
address
includ
optim
peptid
stabil
antimicrobi
activ
pharmaceut
effort
devot
develop
topic
appli
agent
magainin
analog
pexiganan
larg
rel
safeti
topic
therapi
uncertainti
surround
longterm
toxicolog
new
class
system
administr
drug
divers
applic
demonstr
antimicrobi
peptid
antiinfect
agent
broad
antimicrobi
spectrum
antimicrobi
peptid
posit
consider
chemic
condom
limit
spread
sexual
transmit
diseas
includ
neisseria
chlamydia
human
immunodefi
cienci
viru
hiv
herp
simplex
viru
hsv
addit
previous
mention
applic
amp
much
broader
use
peptid
subject
previous
thoroughli
review
sever
author
therefor
select
approach
author
regard
interest
discuss
section
hand
one
noteworthi
exampl
entail
cpppmo
conjug
develop
cooper
avi
biopharma
molecul
develop
show
promis
result
mrna
translat
process
ebola
viru
marburg
viru
becom
increasingli
import
light
recent
ebola
outbreak
variou
vivo
studi
conduct
drug
candid
includ
mice
guinea
pig
primat
recent
conduct
preliminari
clinic
trial
well
obtain
posit
result
phase
trial
anoth
molecul
interest
cation
peptidebas
drug
target
fungal
infect
toenail
show
promis
recent
enter
clinic
studi
novabiot
creat
cyclic
heptaarginin
antimicrobi
peptid
show
potenc
inhibit
fungal
growth
disrupt
cellular
membran
lead
loss
viabil
affect
fungal
cell
cyclic
form
introduc
molecul
claim
enhanc
antifung
capabl
peptid
increas
stabil
recent
year
discov
tat
peptid
show
potent
antibacteri
activ
mic
broad
spectrum
pathogen
includ
gramposit
gramneg
bacteria
aureu
also
fungi
saccharomyc
cerevisia
candida
albican
peptid
intern
without
damag
cell
membran
thu
cytotox
insid
cell
lead
exampl
fast
accumul
nucleu
fungi
caus
cell
cycl
arrest
phase
uptak
tat
peptid
seem
sequencedepend
induc
secondari
structur
nearli
year
discoveri
observ
cpp
penetratin
potent
antimicrob
gramneg
gramposit
bacteria
bacillu
megaterium
mic
measur
peptid
show
cytotox
mammalian
cell
peptid
pvec
uptak
take
place
nonendocytot
mechan
transloc
without
alter
plasma
membran
permeabl
cell
morpholog
intern
process
mainli
local
nuclear
structur
use
carrier
peptid
nucleic
acid
pna
protein
enter
mammalian
microbi
cell
preferenti
permeat
kill
microb
exampl
describ
kill
mycobacterium
smegmati
low
micromolar
dose
normal
human
cell
damag
hydrophob
tryptophanrich
domain
spacer
domain
hydrophil
lysinerich
domain
character
amphipath
structur
broad
antimicrobi
spectrum
gramneg
gramposit
bacteri
strain
weak
antibacteri
activ
bacteriaselect
variant
could
design
replac
sever
glutam
acid
lysin
modifi
ed
peptid
show
high
activ
mic
strain
gramposit
gramneg
bacteria
well
clinic
isol
multidrugresist
pseudomona
aeruginosa
mdrpa
methicillinresist
aureu
mic
certain
chimer
peptid
may
even
consid
blend
amp
cpp
although
report
cpp
strongli
amphipath
cation
peptid
rich
basic
amino
acid
tryptophan
prolin
residu
sequenc
classic
characterist
attribut
amp
abil
cysteinebridg
monom
greatli
improv
transloc
effi
cienci
increas
similar
amp
surprisingli
use
mainli
physic
rout
transloc
membran
howev
rout
alway
oper
endocyt
pathway
altern
transportan
tp
amino
acid
chimer
peptid
compos
neuropeptid
galanin
mastoparanx
link
lysin
exhibit
rapid
nonendocytot
uptak
use
deliveri
peptid
pna
oligom
even
intact
protein
tp
delet
analog
chimer
cpp
transportan
contain
mastoparan
sequenc
lack
toxic
parent
compound
enter
mammalian
microbi
cell
prefer
permeat
kill
microb
aureu
low
micromolar
dose
damag
human
cell
cation
amphipath
model
peptid
map
anoth
cpp
antimicrobi
properti
uptak
peptid
seem
combin
energydepend
energyindepend
mechan
wherea
amphipath
peptid
crucial
uptak
exhibit
antimicrobi
effect
gramposit
bacteria
b
megaterium
gramneg
bacteria
e
coli
low
micromolar
rang
howev
antifung
activ
yeast
cerevisia
observ
poreform
mechan
propos
mpg
amphipath
peptid
also
common
mechan
use
antimicrobi
peptid
tabl
increas
evid
indic
membraneinteract
peptid
fact
may
exhibit
crossfunction
eg
amp
possess
abil
cross
mammalian
cell
membran
nondamag
antivir
peptid
form
distinct
subcategori
antimicrobi
peptid
share
mani
common
featur
antimicrobi
peptid
target
bacteria
fungi
microorgan
peptid
capabl
inhibit
virus
discuss
separ
unlik
microorgan
classifi
ed
live
virus
fall
somewher
live
nonliv
categori
although
possess
capabl
replic
virus
metabol
lack
mean
produc
energi
like
live
thing
help
mitochondria
instead
recogn
host
cell
execut
gene
express
genom
replic
virion
format
take
place
main
reason
antivir
substanc
consid
class
owna
virus
vari
drug
might
show
great
promis
one
type
viru
great
probabl
complet
ineffi
cient
viru
case
lack
effect
even
observ
differ
subtyp
viru
common
exampl
variou
strain
furthermor
main
focu
antibacteri
antifung
even
antitumor
peptid
neutral
organismcel
come
interact
antivir
peptid
must
capabl
disabl
viral
infect
way
host
cell
would
remain
intact
oper
otherwis
host
might
weaken
great
extent
worst
case
even
suffer
termin
organ
failur
main
antivir
approach
use
cppdrug
conjug
cpp
demonstr
possess
antivir
properti
one
virus
antivir
effect
cpp
evid
describ
keogan
et
al
cpp
tatpeptid
interact
subsequ
inhibit
replic
effi
cienci
viru
strain
use
coreceptor
anoth
success
approach
modifi
antivir
molecul
achiev
cellpenetr
capabl
like
direct
taken
zhang
et
al
case
use
hydrocarbon
stapl
creat
stabl
secondari
structur
enhanc
ahel
peptid
follow
success
fi
rst
hydrocarbonstapl
peptid
research
group
produc
wide
rang
antivir
cpp
known
nyad
peptid
antivir
cpp
also
creat
synthet
approach
best
illustr
creation
synthet
lk
peptid
reason
name
compos
either
mainli
leucin
l
lysin
k
residu
key
element
achiev
enhanc
antivir
effi
cienci
increas
ahel
amphipath
characterist
molecul
stress
import
trait
develop
antivir
cpp
synthet
antivir
cpp
also
result
lucki
accid
tri
improv
effi
cienci
cpppna
conjug
ad
fatti
acid
domain
creat
cpp
effi
cient
antivir
agent
even
without
conjug
pna
infect
cell
treat
peptid
also
demonstr
tendenc
releas
nake
viral
nucleocapsid
extrem
immunogen
could
use
vaccinelik
immun
system
stimul
infect
organ
screen
phage
display
librari
also
possibl
look
antivir
agent
penetr
properti
use
approach
tiwari
et
al
yield
peptid
group
possess
altern
charg
possess
repetit
charg
bind
heparin
sulfat
inhibit
viral
entri
attach
cell
surfac
block
viruscel
interact
membran
fusion
main
approach
studi
prophylact
treatment
surfac
cell
note
particl
possibl
intern
case
classifi
ed
cpp
confi
rmed
addit
studi
conjug
acyclovir
order
increas
antivir
effi
cienci
cell
penetr
might
prove
especi
relev
antivir
content
studi
show
screen
methodolog
contain
capabl
identifi
peptid
possess
cellpenetr
featur
previous
mention
amp
describ
show
cpp
properti
well
therefor
use
deliveri
vector
sever
therapeut
diagnost
molecul
treatment
cancer
genet
cardiovascular
infl
ammatori
infecti
diseas
exampl
pyrrhocoricin
consist
amino
acid
antimicrobi
peptid
isol
insect
effect
gramneg
bacteria
almost
inact
gramposit
strain
furthermor
pyrrhocoricin
use
drug
deliveri
system
otvo
et
al
investig
modifi
ed
pyrrhocoricin
dimer
could
success
deliv
peptid
antigen
dendrit
cell
human
fi
broblast
anoth
exampl
antimicrobi
protein
lactoferrin
hlf
human
milk
protein
import
protein
immun
defens
due
antifung
antimicrobi
antivir
activ
truncat
version
peptid
consist
amino
acid
exhibit
antimicrobi
antivir
antitumor
immunolog
activ
describ
enter
differ
cell
effici
eg
hela
rat
uptak
mechan
hlf
peptid
seem
concentrationdepend
concentr
higher
rapid
deliveri
cytoplasm
nucleu
observ
furthermor
uptak
pathway
determin
sensit
rottlerin
protein
kinas
inhibitor
specifi
citi
protein
kinas
c
pkc
also
observ
uptak
argininerich
cpp
tat
uptak
effi
cienci
suppos
conformationdepend
cyclic
structur
requir
bind
heparin
sulfat
correl
lipidinduc
conform
chang
sever
exampl
effi
cient
cargo
deliveri
describ
hlf
peptid
especi
protein
highmolecularweight
complex
success
transport
anoth
peptid
combin
cellperm
antimicrobi
properti
bactenecin
linear
protein
isol
larg
granul
bovin
neutrophil
belong
bactenecin
famili
consist
four
repeat
also
belong
proargrich
famili
describ
antimicrobi
activ
gramneg
bacteria
micromolar
rang
gramposit
strain
antimicrobi
effect
caus
inhibit
intracellular
protein
synthesi
machineri
twostep
mechan
fi
rst
entri
peptid
cytoplasm
second
intracellular
inhibit
target
gener
longer
segment
contain
antibacteri
intracellular
deliveri
region
antibacteri
cellperm
activ
also
synb
vector
antimicrobi
peptid
use
cargo
deliveri
purpos
show
potent
activ
fungi
bacteria
sever
envelop
virus
like
amp
interact
lipid
matrix
bacteri
membran
form
pore
replac
four
cystein
two
valin
led
linear
peptid
still
abl
penetr
cell
effi
cientli
without
cytolyt
help
peptid
transport
coval
coupl
doxorubicin
brain
report
bloodbrain
barrier
cross
high
effi
cienci
without
compromis
integr
anoth
exampl
buforin
ii
antimicrobi
peptid
discov
stomach
tissu
asian
toad
penetr
cell
membran
without
destroy
kill
bacteria
bind
nucleic
acid
modifi
ed
analog
buforin
ii
exhibit
cellpenetr
properti
abl
deliv
gfp
protein
hela
cell
recent
cathelicidinderiv
carrier
peptid
develop
peptid
origin
cation
antimicrobi
protein
fi
rst
isol
rabbit
leukocyt
like
hlf
protein
lipopolysaccharid
bind
protein
structur
also
shorten
variant
exhibit
antimicrobi
properti
lower
micromolar
rang
deliveri
antivir
drug
eukaryot
cell
becom
increasingli
popular
year
specifi
c
therapeut
strategi
inhibit
virus
might
vari
claim
nearli
cppdrug
combin
select
except
make
use
coval
bond
effect
creat
singl
molecul
effi
cient
cellular
penetr
antivir
activ
advantag
noncytotox
wide
select
cell
line
vivo
environ
present
short
overview
studi
success
appli
fusion
peptid
research
common
approach
antivir
treatment
use
pnacpp
conjug
strategi
describ
target
highprofi
le
virus
hcv
effi
cienci
cpp
commonli
use
backbon
molecul
tat
transportan
penetratin
main
target
research
viru
inhibit
cell
cultur
environ
ganguli
et
al
demonstr
effi
cient
uptak
slow
clearanc
level
balbc
mice
suggest
potenti
therapeut
applic
conjug
anoth
interest
result
produc
chaubey
et
al
describ
transportanpna
molecul
previous
shown
display
signifi
cant
antivir
effi
cienci
also
potent
virucid
agent
render
virion
pretreat
conjug
noninfecti
suggest
probabl
prophylact
medic
applic
molecul
pnacpp
tatf
also
use
block
frameshift
process
requir
replic
virus
sarscoronaviru
make
viabl
tool
virus
requir
frameshift
take
place
replic
success
tatbas
applic
pna
shown
lead
japanes
enceph
viru
inhibit
compet
rdrp
interact
bind
site
region
rna
interest
develop
publish
zhuang
et
al
approach
combin
antibodi
fragment
tatpeptid
suppress
revers
transcriptas
activ
isol
primari
blood
mononuclear
cell
make
develop
especi
interest
fact
antirev
antibodi
fragment
antivir
activ
obtain
capabl
strong
inhibit
conjug
tatpeptid
penetratin
also
use
deliv
antibodyderiv
antivir
agent
known
humanizedvhvhh
display
strong
helicas
bind
affi
niti
order
inhibit
hcv
replic
furthermor
singlechain
variabl
fragment
antibodi
attach
cytoplasm
transduct
peptid
order
target
hbv
core
protein
inhibit
nucleocapsid
assembl
replic
process
viru
mino
et
al
report
creation
cellperm
artifici
zincfi
nger
protein
order
reduc
hpv
replic
level
approach
entail
fuse
protein
polyarginin
cpp
allow
block
rep
bind
replic
origin
sequenc
protein
use
inhibit
vsv
viru
combin
tat
peptid
suppress
replic
capabl
cure
ongo
infect
hexaarginin
synthet
peptid
mimick
motif
commonli
found
ctermin
domain
chandipura
viru
p
protein
bind
positivesens
leader
rna
inhibit
viru
replic
heat
shock
protein
fuse
tatpeptid
attempt
enhanc
tcellbas
immun
respons
led
increas
antivir
antitumor
potenc
inhibit
hbv
mice
proteaseinhibit
peptid
develop
hcv
infect
molecul
conjug
select
cpp
fusion
antennapedia
regard
approach
highest
effi
cienci
peptidetarget
capsid
format
success
appli
use
commerci
cppbase
transfect
reagent
chariot
make
develop
especi
interest
one
rare
occas
upon
molecul
interest
conjug
transfect
peptid
coval
employ
noncoval
bond
strategi
instead
approach
target
capsid
viru
also
use
hcv
inhibitionth
capsid
target
fusion
nucleocapsid
bind
subunit
addit
inhibit
envelop
peptid
conjug
also
block
subsequ
viral
particl
releas
less
common
approach
conjug
sirna
molecul
cpp
done
meng
et
al
use
peptid
backbon
sirna
design
utr
hcv
manag
effi
cientli
enter
cell
inhibit
replic
viral
rna
pmo
util
approach
murin
hepat
viru
member
coronaviru
famili
hold
better
known
member
sar
variou
argininerich
ppmo
combin
compar
result
select
rahxr
ahxbppmo
tatppmo
base
deliveri
effi
cienci
splicecorrect
model
system
antivir
effi
cienci
target
nucleotid
viral
genom
cppconjug
pmo
target
region
intern
ribosom
entri
site
shown
hold
great
potenc
coxsackieviru
known
caus
viral
myocard
cell
cultur
mice
show
perspect
therapeut
research
pmo
combin
argininerich
cpp
also
report
capabl
inhibit
ebola
marburg
virus
respect
main
mechan
action
molecul
inhibit
viral
mrna
translat
lead
inhibit
whole
replic
process
larg
number
possibl
present
use
cpp
combat
viral
infect
applic
peptid
instead
help
research
understand
viru
thoroughli
may
appar
fi
rst
possibl
applic
present
almost
type
cpp
come
fundament
research
consid
exampl
cpp
deliveri
vector
proven
effect
whatsoev
regard
viral
infectionrepl
cycl
also
show
consider
cytotox
effect
host
cell
cpp
combin
semliki
forest
viru
member
alphaviru
famili
open
numer
possibl
gain
insight
properti
viru
behavior
molecul
interest
introduc
environ
lack
interfer
becom
especi
import
take
account
fact
wide
use
transfect
method
electropor
lipofect
either
damag
cell
great
extent
inhibit
infect
replic
capabl
virus
result
data
viru
consid
unreli
research
applic
cpp
limit
experiment
setup
viru
left
undisturb
mention
numer
occas
cppbase
vector
use
deliv
antivir
substanc
cell
approach
combin
fact
cpp
affect
virus
allow
conduct
research
relat
viral
replic
introduc
cppdrug
conjug
cellular
environ
complet
inhibit
latestag
virion
format
could
creat
set
easier
observ
viral
replic
without
need
creat
replicon
model
origin
viru
downsid
carri
replic
similar
way
viru
interest
still
essenc
shorten
version
origin
genom
result
possibl
chang
replic
speed
cellular
immun
respons
case
highli
mutagen
virus
would
also
open
possibl
effi
cientli
research
abil
virus
overcom
obstacl
life
cyclefor
exampl
benefi
cial
mutat
viru
capabl
obtain
certain
replic
stage
pathway
block
similar
capabl
observ
zhang
et
al
observ
mutat
viral
protein
overcom
antivir
effect
cpp
molecul
anoth
interest
research
topic
intracellular
detect
virus
cpp
vector
success
use
transport
small
molecular
beacon
eukaryot
cell
goal
observ
behavior
virus
realtim
good
exampl
experi
yeh
et
al
describ
use
wide
use
tatpeptid
transport
nucleaseresist
molecular
beacon
detect
coxsackieviru
replic
use
approach
verifi
presenc
viral
rna
cell
abl
observ
spread
replic
one
cell
anoth
great
accuraci
small
molecul
transport
use
identifi
variou
interact
certain
viru
region
might
host
cell
caignard
et
al
use
tatconjug
peptid
version
measl
viru
v
protein
character
way
intracellular
interact
viru
signal
pathway
take
place
antimicrobi
peptid
prove
highli
effi
cient
versatil
therapeut
system
allow
inhibit
variou
pathogen
advent
cpp
two
fi
eld
evolv
close
result
variou
combin
adopt
antimicrobi
strategi
novel
approach
demonstr
line
amp
cpp
thin
time
sever
molecul
display
characterist
common
group
addit
cpp
made
serv
antimicrobi
fundament
research
purpos
either
conjug
variou
inhibitori
molecul
increas
spectrum
fi
eld
